Form 4: Applied Therapeutics CEO Sells Shares to Cover Tax Obligations

Shoshana Shendelman, CEO of Applied Therapeutics, sold shares to cover tax withholding obligations related to the vesting and settlement of restricted stock units.

Summary

• On March 14, 2024, Shoshana Shendelman, the President and CEO of Applied Therapeutics, Inc., sold 318,573 shares of common stock at a weighted average price of $5.39.
• The sale was executed to cover tax withholding obligations associated with the vesting and settlement of compensatory Restricted Stock Units.
• Following the transaction, Shendelman directly owns 3,817,814 shares.
• She also has indirect ownership through various trusts and entities, including 1,750,000 shares through a grantor retained annuity trust, 1,492,094 shares through a family trust controlled by her spouse, 709,720 shares through her spouse, 290,280 shares through a family trust controlled by her, and 88,397 shares through Clearpoint Strategy Group LLC.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to a stock sale for tax purposes. It doesn't inherently convey positive or negative sentiment about the company's prospects.

Industry Context

Executive stock sales are a common occurrence, often related to compensation and tax planning. The market typically assesses these sales based on their size and the executive's stated reasons.

Stakeholder Impact

• The stock sale could have a minor impact on shareholders due to the increased supply of shares, but the stated reason (tax obligations) mitigates potential concerns.

Key Dates